Related Experiment Videos
Tricarboxylic acid cycle intermediates in chronic renal failure
S Biasioli1, M Feriani, L Bigi
1Nephrology and Dialysis Unit, Legnago Hospital, Italy.
Summary
Uraemic patients show significantly higher levels of key metabolic intermediates in the Tricarboxylic Acid (TCA) cycle. This accumulation, particularly of citrate and malate, suggests altered cellular metabolism in early-stage kidney disease.
Area of Science:
- Biochemistry
- Nephrology
- Metabolic pathways
Background:
- Uraemia, a condition associated with kidney disease, can lead to metabolic disturbances.
- The Tricarboxylic Acid (TCA) cycle is central to cellular energy production.
- Anaplerotic reactions replenish TCA cycle intermediates.
Purpose of the Study:
- To investigate serum concentrations of TCA cycle intermediates in uraemic patients not yet on dialysis.
- To compare these levels with those in healthy control subjects.
- To explore potential mechanisms behind observed metabolic changes.
Main Methods:
- Serum samples were collected from 21 uraemic patients and 18 control subjects.
- Concentrations of specific TCA cycle intermediates (citrate, fumarate, oxalacetate, malate) were measured.
- Total TCA intermediate concentrations were calculated and compared between groups.
Main Results:
- Serum levels of citrate, fumarate, oxalacetate, and malate were significantly elevated in uraemic subjects.
- The total concentration of TCA cycle intermediates was approximately threefold higher in uraemic patients compared to controls.
- The observed metabolic pattern resembles that seen in rat skeletal muscle during exercise with increased acetyl CoA.
Conclusions:
- Early-stage uraemia is associated with a significant accumulation of TCA cycle intermediates in serum.
- This accumulation may be driven by anaplerotic reactions, such as those catalyzed by pyruvate carboxylase and malic enzyme.
- The findings suggest a distinct metabolic profile in uraemia, potentially linked to altered energy metabolism.